Follow the HLB바이오스텝 share price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, HLB바이오스텝 has published 103 public disclosures. Market capitalisation: €39.8bn. The latest transaction was disclosed on 21 July 2026 (Purchase). Among the most active insiders: 한국증권금융. Every trade is accessible without an account.
100
Insider Decl.
n/a
Thresholds
€1m
34 ops.
Buy Volume
n/a
38 ops.
Sell Volume
10Σ signal
Buys €1mn/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 22,292 of 29,057 companies
33.2
score / 100
Value
29
Quality
37
FCF yld2.5%
Earn yld-46%
EV/EBITDA·
ROE-18%
Gross mgn76%
Net mgn-26%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.